These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38502780)

  • 21. The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist.
    Hossain MA; Samuel CS; Binder C; Hewitson TD; Tregear GW; Wade JD; Bathgate RA
    Amino Acids; 2010 Jul; 39(2):409-16. PubMed ID: 20043231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis.
    Chow BSM; Kocan M; Shen M; Wang Y; Han L; Chew JY; Wang C; Bosnyak S; Mirabito-Colafella KM; Barsha G; Wigg B; Johnstone EKM; Hossain MA; Pfleger KDG; Denton KM; Widdop RE; Summers RJ; Bathgate RAD; Hewitson TD; Samuel CS
    J Am Soc Nephrol; 2019 Nov; 30(11):2191-2207. PubMed ID: 31511361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells.
    Kern A; Bryant-Greenwood GD
    Endocrinology; 2009 May; 150(5):2419-28. PubMed ID: 19116340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-fibrotic actions of relaxin are mediated through AT
    Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
    FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
    Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
    Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the relaxin/insulin-like family peptide receptor 1 and 2 with small molecule compounds.
    Ng HH; Esteban-Lopez M; Agoulnik AI
    Mol Cell Endocrinol; 2019 May; 487():40-44. PubMed ID: 30590098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats.
    de Ávila C; Chometton S; Lenglos C; Calvez J; Gundlach AL; Timofeeva E
    Behav Brain Res; 2018 Jan; 336():135-144. PubMed ID: 28864207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor.
    Hossain MA; Man BC; Zhao C; Xu Q; Du XJ; Wade JD; Samuel CS
    Biochemistry; 2011 Mar; 50(8):1368-75. PubMed ID: 21229994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemically synthesized dicarba H2 relaxin analogues retain strong RXFP1 receptor activity but show an unexpected loss of in vitro serum stability.
    Hossain MA; Haugaard-Kedström LM; Rosengren KJ; Bathgate RA; Wade JD
    Org Biomol Chem; 2015 Nov; 13(44):10895-903. PubMed ID: 26368576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
    Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
    J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1.
    Hossain MA; Kocan M; Yao ST; Royce SG; Nair VB; Siwek C; Patil NA; Harrison IP; Rosengren KJ; Selemidis S; Summers RJ; Wade JD; Bathgate RAD; Samuel CS
    Chem Sci; 2016 Jun; 7(6):3805-3819. PubMed ID: 30155023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relaxin peptide hormones are protective during the early stages of ischemic stroke in male rats.
    Bergeron LH; Willcox JM; Alibhai FJ; Connell BJ; Saleh TM; Wilson BC; Summerlee AJ
    Endocrinology; 2015 Feb; 156(2):638-46. PubMed ID: 25456068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment.
    Jelinic M; Leo CH; Post Uiterweer ED; Sandow SL; Gooi JH; Wlodek ME; Conrad KP; Parkington H; Tare M; Parry LJ
    FASEB J; 2014 Jan; 28(1):275-87. PubMed ID: 24036884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease.
    Chen TY; Li X; Hung CH; Bahudhanapati H; Tan J; Kass DJ; Zhang Y
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1194. PubMed ID: 32100955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
    Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
    Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat.
    Filonzi M; Cardoso LC; Pimenta MT; Queiróz DB; Avellar MC; Porto CS; Lazari MF
    Reprod Biol Endocrinol; 2007 Jul; 5():29. PubMed ID: 17623071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting.
    Bathgate RAD; Kocan M; Scott DJ; Hossain MA; Good SV; Yegorov S; Bogerd J; Gooley PR
    Pharmacol Ther; 2018 Jul; 187():114-132. PubMed ID: 29458108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.
    Kong RC; Petrie EJ; Mohanty B; Ling J; Lee JC; Gooley PR; Bathgate RA
    J Biol Chem; 2013 Sep; 288(39):28138-51. PubMed ID: 23926099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using the novel HiBiT tag to label cell surface relaxin receptors for BRET proximity analysis.
    Hoare BL; Kocan M; Bruell S; Scott DJ; Bathgate RAD
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00513. PubMed ID: 31384473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxin.
    Chan LJ; Rosengren KJ; Layfield SL; Bathgate RA; Separovic F; Samuel CS; Hossain MA; Wade JD
    J Biol Chem; 2012 Nov; 287(49):41152-64. PubMed ID: 23024363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.